BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 23918309)

  • 1. Association between cytochrome P450 1A1 MspI polymorphism and endometrial cancer risk: a meta-analysis.
    Han L; Liu Y; Cao W; Yuan X; Li C
    Tumour Biol; 2013 Oct; 34(5):2545-50. PubMed ID: 23918309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CYP1A1 MspI polymorphism is associated with prostate cancer susceptibility: evidence from a meta-analysis.
    Ding G; Xu W; Liu H; Zhang M; Huang Q; Liao Z
    Mol Biol Rep; 2013 May; 40(5):3483-91. PubMed ID: 23475304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does cytochrome P450 1A1 MspI polymorphism increase acute lymphoblastic leukemia risk? Evidence from 2013 cases and 2903 controls.
    Zhuo W; Zhang L; Qiu Z; Zhu B; Chen Z
    Gene; 2012 Nov; 510(1):14-21. PubMed ID: 22964275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative assessment of the association between CYP1A1 A4889G polymorphism and endometrial cancer risk.
    Li M; Li YY; Xin XY; Han Y; Wu TT; Wang HB
    Tumour Biol; 2013 Dec; 34(6):3675-80. PubMed ID: 23860774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of CYP1A1 MspI polymorphism in the esophageal cancer risk: a meta-analysis in the Chinese population.
    Zheng H; Zhao Y
    Eur J Med Res; 2015 Mar; 20(1):46. PubMed ID: 25886559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cytochrome P4501A1 gene polymorphisms and endometriosis: a meta-analysis.
    Fan W; Huang Z; Xiao Z; Li S; Ma Q
    J Assist Reprod Genet; 2016 Oct; 33(10):1373-1383. PubMed ID: 27525656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MspI and Ile462Val polymorphisms in CYP1A1 and overall cancer risk: a meta-analysis.
    Wu B; Liu K; Huang H; Yuan J; Yuan W; Wang S; Chen T; Zhao H; Yin C
    PLoS One; 2013; 8(12):e85166. PubMed ID: 24391993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative assessment of the associations between CYP1A1 polymorphisms and gastric cancer risk.
    Guo R; Guo X
    Tumour Biol; 2012 Aug; 33(4):1125-32. PubMed ID: 22359202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of CYP1A1 MspI polymorphism with oral cancer risk in Asian populations: a meta-analysis.
    Xu JL; Xia R; Sun L; Min X; Sun ZH; Liu C; Zhang H; Zhu YM
    Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27323067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytochrome P450 1A1 gene polymorphisms and endometrial cancer risk: a meta-analysis.
    Sergentanis TN; Economopoulos KP; Choussein S; Vlahos NF
    Int J Gynecol Cancer; 2011 Feb; 21(2):323-31. PubMed ID: 21270613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CYP1A1 MspI polymorphism and acute myeloid leukemia risk: meta-analyses based on 5018 subjects.
    Zhuo W; Zhang L; Wang Y; Zhu B; Chen Z
    J Exp Clin Cancer Res; 2012 Jul; 31(1):62. PubMed ID: 22846179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CYP1A1 MspI and exon7 gene polymorphisms and lung cancer risk: an updated meta-analysis and review.
    Zhan P; Wang Q; Qian Q; Wei SZ; Yu LK
    J Exp Clin Cancer Res; 2011 Oct; 30(1):99. PubMed ID: 22014025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative synthesis of the association between the cytochrome P450 1A1 Ile462Val polymorphism and prostate cancer risk.
    Han G; Ma Y; Liu P; Wei X; Zhang X; Zhu F
    Tumour Biol; 2013 Jun; 34(3):1511-6. PubMed ID: 23381648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of CYP1A1 polymorphisms on the risk of lung cancer: a global meta-analysis based on 71 case-control studies.
    Chen Z; Li Z; Niu X; Ye X; Yu Y; Lu S; Chen Z
    Mutagenesis; 2011 May; 26(3):437-46. PubMed ID: 21402622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CYP1A1 MspI polymorphisms and lung cancer risk: an updated meta-analysis involving 20,209 subjects.
    Ji YN; Wang Q; Lin XQ; Suo LJ
    Cytokine; 2012 Aug; 59(2):324-34. PubMed ID: 22579698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytochrome P450 1A1 (CYP1A1) polymorphism and susceptibility to esophageal cancer: an updated meta-analysis of 27 studies.
    Gong FF; Lu SS; Hu CY; Qian ZZ; Feng F; Wu YL; Yang HY; Sun YH
    Tumour Biol; 2014 Oct; 35(10):10351-61. PubMed ID: 25048966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of association between CYP1A1 polymorphisms and risk of bladder cancer: a meta-analysis.
    Lu Y; Zhang XL; Xie L; Li TJ; He Y; Peng QL; Deng Y; Wang J; Qin X; Li S
    Asian Pac J Cancer Prev; 2014; 15(9):4071-7. PubMed ID: 24935599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significant association between CYP1A1 T3801C polymorphism and cervical neoplasia risk: a systematic review and meta-analysis.
    Xia L; Gao J; Liu Y; Wu K
    Tumour Biol; 2013 Feb; 34(1):223-30. PubMed ID: 23055196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytochrome P450 1A1 (CYP1A1) gene polymorphisms and ovarian cancer risk: a meta-analysis.
    Sergentanis TN; Economopoulos KP; Choussein S; Vlahos NF
    Mol Biol Rep; 2012 Nov; 39(11):9921-30. PubMed ID: 22733497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interaction between smoking and CYP1A1 MspI polymorphism on lung cancer: a meta-analysis in the Chinese population.
    Zhang LP; Wang CP; Li LH; Tang YF; Li WC
    Eur J Cancer Care (Engl); 2017 Sep; 26(5):. PubMed ID: 26918783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.